Table III.
OA n (%) | Joint pain n (%) | OR (95% CrI)∗ | OR (95% CrI)† | |
---|---|---|---|---|
Total | 254 (36) | 447 | – | – |
Male | 95 (35) | 173 | 1.00 | 1.00 |
Female | 159 (37) | 274 | 1.16 (0.82, 1.58) | 1.19 (0.81, 1.71) |
Age | ||||
50–64 | 90 (30) | 213 | 1.00 | 1.00 |
65–74 | 90 (37) | 153 | 1.41 (0.97, 1.97) | 1.59 (1.07, 2.37) |
75+ | 74 (48) | 81 | 2.04 (1.30, 2.96) | 2.56 (1.52, 4.03) |
Social class | ||||
Low | 117 (35) | 216 | 1.00 | 1.00 |
High | 130 (39) | 206 | 1.19 (0.85, 1.66) | 1.14 (0.77, 1.67) |
Unknown | 7 (22) | 25 | 0.52 (0.19, 1.09) | 0.39 (0.11, 0.97) |
BMI group | ||||
Normal | 80 (34) | 155 | 1.00 | 1.00 |
Overweight | 101 (35) | 186 | 1.09 (0.73, 1.58) | 1.01 (0.65, 1.50) |
Obese | 60 (42) | 83 | 1.60 (0.98, 2.49) | 1.67 (0.97, 2.64) |
Unknown | 13 (36) | 23 | 1.16 (0.49, 2.22) | 1.08 (0.41, 2.38) |
Neither depressed nor anxious | 133 (37) | 222 | 1.00 | 1.00 |
Depressed or anxious | 114 (35) | 213 | 0.87 (0.61, 1.16) | 0.79 (0.52, 1.15) |
Recorded site | ||||
Knee | 144 (42) | 203 | 1.00 | 1.00 |
Hip | 36 (27) | 99 | 0.39 (0.23, 0.62) | 0.38 (0.22, 0.60) |
Hand/wrist | 39 (43) | 52 | 1.09 (0.65, 1.68) | 1.24 (0.69, 2.01) |
Foot/ankle | 35 (27) | 93 | 0.43 (0.26, 0.67) | 0.38 (0.21, 0.64) |
No. of pain sites, median (IQR)‡ | 2 (1–3) | 2 (1–3) | 1.06 (0.93, 1.22) | 1.05 (0.87, 1.25) |
No pain interference | 86 (31) | 190 | 1.00 | 1.00 |
Pain interference | 162 (40) | 246 | 1.33 (0.94, 1.59) | 1.35 (0.82, 1.99) |
No analgesic | 99 (33) | 202 | 1.00 | 1.00 |
Any analgesic∗∗ | 151 (38) | 245 | 1.22 (0.86, 1.72) | – |
Basic | 44 (40) | 65 | 1.43 (0.85, 2.27) | 1.31 (0.71, 2.13) |
Weak/moderate opioid | 34 (38) | 55 | 1.29 (0.74, 2.06) | 1.07 (0.58, 1.82) |
NSAID | 15 (35) | 28 | 0.98 (0.45, 1.83) | 0.91 (0.36, 1.83) |
Strong opioid | 62 (39) | 97 | 1.16 (0.73, 1.76) | 0.97 (0.58, 1.53) |
Multilevel logistic regression, level 1 (patient), level 2 (practice), unadjusted.
Multilevel logistic regression, level 1 (patient), level 2 (practice), adjusted for other listed variables.
Self-reported in baseline survey (knee, hip, hand, foot).
Prescribed on day of index consultation or in following 0–14 days.